logo
North Dakotan leads while living with HIV, earns Bush Fellowship

North Dakotan leads while living with HIV, earns Bush Fellowship

Yahoo3 days ago

Jason Grueneich, pictured June 2, 2025, at the Capitol in Bismarck, is a 2025 Bush Fellow. Grueneich works to build support for people living with HIV, including advocating for legislation approved earlier this year. (Amy Dalrymple/North Dakota Monitor)
A Bismarck man who has experienced substance abuse, recovery and living with HIV is hoping to develop his leadership skills after being awarded a Bush Foundation fellowship.
'I've been able to change my own life and work to help others to do the same,' Jason Grueneich told the North Dakota Monitor. 'I'm just lucky to be alive and here doing the work. And it's amazing that the Bush Foundation saw something in me.'
Grueneich's work includes being an advocate for those living with HIV. He created Bismarck's first LGBTQ+ recovery group and this year founded Shine Bright and Live, an HIV-focused nonprofit, and helped repeal a North Dakota state law that he said stigmatized people who are HIV positive.
Grueneich is one of three North Dakotans awarded a Bush Fellowship in 2025. Up to 30 Bush Fellows are selected each year to receive up to $150,000 to support their leadership goals. Fellows can come from any sector — including business, nonprofit and government, according to the Bush Foundation.
Grueneich said the Bush Foundation isn't so much about funding a project but investing in leaders.
'Leaders work to bring as many people with them as possible,' Grueneich said. 'It ripples out into the community and raises people up.'
Gruenich grew up in Bismarck but said he moved away, developed a substance abuse problem and became infected with HIV, the virus that causes AIDS.
He returned to Bismarck and went through a recovery program in 2016.
Since then, 'I have dedicated myself to community,' Grueneich said.
Two other North Dakota also were awarded a Bush Fellowship.
Sarah Dixon-Hackey of West Fargo will pursue certification in suicide prevention skills, expand her expertise in digital media, and deepen her research into cultural disparities in care, according to a news release. She has created storytelling projects with college students and produced podcasts for refugee families to amplify underrepresented voices, especially on the topic of mental health.
Richard Pallay III of Fargo has used his experience as a DJ to found the cultural initiative WEAREONE. He also launched Soul Dads, a peer support network for Black fathers that blends mentorship with creative expression. Pallay will use his Bush Fellowship to launch a statewide artist network and scale Soul Dads into a model that can be replicated, the news release said.
Grueneich chairs the North Dakota HIV Advisory Board while working in state government. He has worked for the Department of Transportation for the past five years and is operations manager for the driver's license division.
After founding Shine Bright and Live in January, Grueneich spent time at the Capitol advocating for the repeal of a state law that makes it a felony to willfully transfer body fluid containing the HIV virus.
Rep. Gretchen Dobervich, D-Fargo, sponsored House Bill 1217 that repeals the law.
She said the law singled out HIV from other infectious diseases by creating the felony crime and discouraged people from getting tested for HIV, leading to the potential spread of the virus.
The law, 'had the opposite effect of what it was intended,' Dobervich said.
She said Grueneich was instrumental in getting the bill through the Legislature.
'He was able to make the issue real,' Dobervich said.
Testifying in front of a legislative committee was new for him, Grueneich said.
'A leader faces fears,' Grueneich said. 'Somebody living with HIV, standing in front of the Legislature numerous times when there's a lot of stigma about HIV can be daunting.'
In his testimony, Gruenich cited President Donald Trump, who in his first term in 2019, used the State of the Union address to announce a plan to end the HIV epidemic.
Grueneich said it was a way to find common ground on HIV issues.
'Unfortunately, we see now the administration is cutting funding for HIV prevention. It's cutting funding for the years of work we've had on finding HIV vaccination or care,' he said.
Grueneich said one way he hopes to benefit from the Bush Fellowship is learning how to deal with traumatic life experiences that come with working with high-risk communities such as HIV and recovery.
'You're continually working through trauma and loss,' Grueneich said. 'I want to learn how to heal and process those losses, so I can teach others how they can process that and then refill their cups so they can keep doing the work that's necessary.'
Editor's note: The North Dakota Monitor is a recipient of funding from the Bush Foundation through its media partnership program.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
SUPPORT: YOU MAKE OUR WORK POSSIBLE

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ribbon ties together fraying AIDS response
Ribbon ties together fraying AIDS response

Hamilton Spectator

time30 minutes ago

  • Hamilton Spectator

Ribbon ties together fraying AIDS response

Around the world, access to lifesaving HIV treatment is at risk. A shift in U.S. foreign aid policy, which began the day President Donald Trump took office with an immediate freeze on international assistance, is now threatening decades of global progress. Cuts to funding for HIV treatment and prevention in more than 50 countries could undo hardwon gains and trigger a public health crisis with devastating consequences. The Ribbon Community (formerly AIDS Vancouver), or Ribbon for short, is based in Vancouver and is a vital hub that connects the diverse communities at the forefront of this ongoing fight. The organization works to amplify voices, foster collaboration and strengthen the collective effort. Through programs like Peer Navigation, the Grocery Program (which provides financial support), and the Corner Program (which helps sex workers and substance users build community), its mandate is clear: to support and empower individuals as they navigate the lasting impact of HIV and the stigma that still surrounds it. Sarah Chown, Ribbon's executive director, believes that it is especially important to honour the ongoing relationship between Indigenous Peoples and the land, and the ongoing impact of colonialism, as well as having a diverse peer program. Ribbon is dedicated to fostering Indigenous leadership within the HIV movement. Rob Lamoureux, a Cree/Métis knowledge keeper and peer navigator at Ribbon Community, plays a crucial role in supporting his peers. With lived experience of substance use, Lamoureux is a strong advocate for harm reduction. For him, working with Ribbon is not just a job — it's a passion and a source of joy. Lamoureux served on the Indigenous committee for two years and still provides a sacred smudge once a month. He feels a deep honour in facilitating sacred pipe ceremony for equinox and solstice. 'I believe access to ceremony for Indigenous at-risk people is crucial to getting well again and to achieve sobriety,' he says. 'It was essential for me to connect to traditional practices in my search for a sober life.' Hazel Cardinal, who is Cree, emphasized the importance of Indigenous representation. 'Having Indigenous peers who work directly with the community is vital,' she says. She also noted that the majority of the peers at Ribbon are Indigenous. Having someone who sees you and listens to you 'breaks walls down,' says Cardinal. 'It is a great feeling knowing that I can be there to listen, to relate and just be.' Morgan Johnston, one of the case managers at Ribbon, says that a sense of 'belonging and connection to community' is crucial for the community's healing. 'It is so important to acknowledge that so much HIV work from the bigger HIV organizations hasn't included Indigenous leadership, or very strong relationships with our host nations,' says Johnston. While Ribbon strives to foster Indigenous leadership, its commitment to diversity extends further. The organization also represents and supports members of Latino, South Asian, Arabic-speaking, African, Caribbean and Black communities, recognizing that a truly effective HIV response must reflect the full spectrum of those affected — across borders, cultures and lived experiences. That's what makes Ribbon's work so vital. While U.S.-led funding cuts threaten to escalate the HIV epidemic in countries where poverty already limits access to care, the impact won't stop at national borders. Families in Canada — particularly those from immigrant and refugee communities — often have deep personal ties to the regions most affected. The consequences will be felt not just statistically, but intimately, through loved ones back home who may now face dwindling resources and rising risk. Additionally, while medications like PrEP and PEP have transformed HIV prevention by giving people more control over their health, access to these tools remains deeply unequal. (PrEP, or Pre-Exposure Prophylaxis, is medication taken before a possible HIV exposure, while PEP, or Post-Exposure Prophylaxis, is taken after a possible HIV exposure). The funding cuts initiated by the Trump administration will likely keep these life-saving options out of reach for many around the world. It's a stark reminder that scientific progress means little without equitable access — and that political decisions made far away can have life-ordeath consequences for communities already facing systemic barriers. In the face of global funding cuts and widening inequities, the Ribbon Community is more vital than ever. Its work is a powerful reminder of what community care can look like: rooted in resilience, driven by lived experience, and impossible to overlook. Jathinder Sandhu is a Surrey resident and a published poet, writer and member of The Shift peer newsroom. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .

"Gasping": Scientists Make Breakthrough Toward Full Cure for HIV
"Gasping": Scientists Make Breakthrough Toward Full Cure for HIV

Yahoo

time40 minutes ago

  • Yahoo

"Gasping": Scientists Make Breakthrough Toward Full Cure for HIV

Researchers say they've taken a major step toward finding a cure for HIV. As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body altogether. As detailed in a paper published in the journal Nature Communications, the team developed a way to send messenger RNA into cells, to root out the hiding virus by fully enveloping it in a bubble of formulated fat called lipid nanoparticles (LNPs). The genetic molecules then instruct the cells to make the virus visible. Author and Doherty Institute research fellow Paula Cevaal told the Guardian that it was "previously thought impossible" to deliver mRNA into HIV-containing white blood cells. But thanks to a new type of LNPs, dubbed LNP X, the team found a way for these cells to accept the mRNA. "Our hope is that this new nanoparticle design could be a new pathway to an HIV cure," she added. The human immunodeficiency virus attacks the human body's immune system and can lead to deadly AIDS if left untreated. Despite decades of research, there's still no effective cure for the disease; though a handful of patients have been fully cured of HIV, the treatments remain brutally complex and expensive. While the number of people in the United States living with HIV has decreased since 2018, over 39,000 new patients were diagnosed in 2023. The latest research came with such surprising findings that the team didn't believe it at first. "We were overwhelmed by how [much of a] night and day difference it was — from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'wow,'" Cevaal told the Guardian. While it's a promising step in the right direction, scientists still have to figure out whether making the hidden virus visible will cause the body's immune system to deal with it. Other possibilities include developing new ways to combine their findings with other gene therapies to ultimately cure HIV. Before the latest technique can be used in humans, it would also have to be put through its paces, from animal experiments to human safety trials, a process that could easily take many years. And Cevaal appears to be realistic about those chances. "In the field of biomedicine, many things eventually don't make it into the clinic — that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality," she told the Guardian. "But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus." "So from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans," she added. Beyond HIV, the researchers are hoping their LNP-based mRNA delivery method could be applied to other diseases as well, including certain types of cancer. More on HIV: Religious Conservatives Trying to End Insurance Coverage of Incredibly Effective Anti-HIV Drug

England is launching a gonorrhea vaccine. Is Canada next?
England is launching a gonorrhea vaccine. Is Canada next?

Yahoo

timean hour ago

  • Yahoo

England is launching a gonorrhea vaccine. Is Canada next?

England will soon begin administering a vaccine to high-risk individuals that may reduce their chances of contracting gonorrhea, but a similar program is not yet in the cards for Canada. According to studies cited by England's National Health Service, the 4CMenB vaccine, which is presently used in Canada for immunization against meningitis B, has an effectiveness of 32.7 to 42 per cent against gonorrhea. To combat rising infection rates, the health service said last month it will begin administering the vaccine free of charge in August for those deemed to be at high risk of contracting gonorrhea, including gay and bisexual men who have a history of sexually transmitted infection or multiple sex partners. But the vaccine has not been authorized for this use in Canada, even as cases of gonorrhea continue to rise across the country. According to the most recent national statistics, rates of the sexually transmitted infection more than tripled in Canada from 2010 to 2022, going from 11,381 in 2010 to 35,956 in 2022. Gonorrhea, often referred to as "the clap," is passed on through oral, anal or genital sex. People who've been infected, especially women, often show no symptoms at all. If left untreated, it can have serious health risks. In an interview with CBC News on Monday, Calgary physician Caley Shukalek, the chief medical officer for Freddie, an online service that focuses on 2SLGBTQ+ health care, said it's still too soon to know how effective the 4CMenB vaccine will be at preventing new gonorrhea infections. Early research hasn't been conclusive either, Shukalek said, citing another study conducted by researchers in France that suggested the vaccine may not have any statistical effect on gonorrhea rates. "I think in the medical community, there's still a bit of skepticism," he said, noting that more research needs to be done before the true impact is known. The potential upside is promising enough, however, that Shukalek said he has begun prescribing the vaccine to some people who are willing to pay for it out of pocket or through private health insurance. "Its safety is very well established, so for those at high risk of STIs, I think this is a very worthwhile thing and something that could be considered," he said. "But because it's kind of what we call off-label, it absolutely is something that needs to be a discussion between a prescriber and a patient to make sure that it's the right decision based on their individual risk." The vaccine is typically administered in two phases, he said, with the second dose coming at least four weeks after the first. Chris Aucoin is the executive director of the Health Equity Alliance of Nova Scotia, a group that advocates for those living with HIV and members of the 2SLGBTQ+ community. He's aware of the latest research on the use of the 4CMenB vaccine to help prevent the spread of gonorrhea, but notes that even if it's approved, it would only be one part of a potential prevention strategy. Aucoin said the best thing people can do now and in the future to prevent the spread of gonorrhea is to get tested regularly. "If people are concerned about gonorrhea rates, which are too high … the biggest factor in that for me is the fact that people don't test regularly enough." He said the recent launch of Nova Scotia's STI Care Now program, which mails out free at-home testing kits for chlamydia, gonorrhea and HIV to anyone interested across the province, is a positive step toward making this easier. "We now have a tool that's accessible to them in a way that's never been the case in Nova Scotia," he said. In a statement, the Public Health Agency of Canada said the National Advisory Committee on Immunization is monitoring the latest research on the 4CMenB vaccine. In a 2023 report, the advisory committee noted that although the vaccine is not currently authorized for this purpose, it may "offer some level of cross-protection against gonococcal infection." The agency said it expects the committee to further assess this possibility as more evidence becomes available. Nova Scotia's Department of Health and Wellness echoed this statement, noting that it takes its cues on immunization from the committee Those looking to pay out of pocket for the vaccine in the private market would be looking at around $200 per dose, the department said. In 2024, there were 368 new cases of gonorrhea reported in Nova Scotia. MORE TOP STORIES

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store